Cryo-Cell International Inc. CCEL
4.24
0.21
5.21%
as of 25 Sep
- Market cap
- $32.5M
- P/E
- 0.0×
Follow CCEL
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
3.88% | 15.27% | 16.12% | 14.80% | |
| (0.75%) | (3.84%) | (4.26%) | (3.94%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(3.28%) | (18.69%) | (18.79%) | (15.37%) | |
Average Days of Receivables |
78.56 | 79.16 | 79.53 | 81.03 | |
Free Cash Flow per Share |
0.78 | 0.66 | 0.63 | 0.76 | |
Free Cash Flow |
6.30 | 5.36 | 5.06 | 6.11 | |
Capital Expenditures |
(0.06) | (0.12) | (0.12) | (0.21) | |
Piotroski F-Score |
6.00 | 5.00 | 5.00 | 5.00 | |
| Other line items | |||||
Cash ROIC |
(3,127.36%) | (113.20%) | (89.67%) | (96.96%) | |
Accounts Receivable Turnover |
4.63 | 4.46 | 4.46 | 4.50 | |
Accounts Payable Turnover |
3.20 | 3.10 | 2.33 | 2.70 | |
Inventory Turnover |
10.63 | 13.83 | 12.96 | 13.92 | |
Average Days of Payables |
129.30 | 142.05 | 170.97 | 151.29 | |
Days of Inventory on Hand |
32.44 | 20.23 | 18.49 | 16.48 | |
Tax Rate |
(1.33) | 0.04 | (0.05) | (0.03) | |
Research and Development Expense of Revenue |
1.88% | 1.19% | 1.10% | 1.00% | |
Selling, General and Administrative Expense of Revenue |
58.86% | 57.72% | 59.44% | 60.89% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(13.42) | (2.26) | (1.94) | (2.56) | |
Depreciation/Fixed assets |
0.07 | 0.07 | 0.07 | 0.07 | |
Capex/Depreciation |
(0.04) | (0.08) | (0.09) | (0.15) | |
Revenue per Share |
3.94 | 3.91 | 3.88 | 3.86 | |
Operating CF per Share |
0.79 | 0.68 | 0.64 | 0.78 | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | |
Net Profit Margin |
(1.49%) | (7.70%) | (8.52%) | (7.92%) |
Columns are period end dates